chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 36-year-old female patient (gravida 5, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Disease Crohns since 2009, Alcohol use (Prior use), Nicotine dependence (Prior use) and Marijuana use (Prior use). Concurrent medical conditions included Allergy (Erythromycin-when she was a kid). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for Pregnancy, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and CERTOLIZUMAB PEGOL (CIMZIA) for an unknown indication.    On 24-Feb-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in October 2020 and the estimated date of delivery was 07-Jul-2021. On 24-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 24-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) to be not related.    on 02-DEC-2020 and 16-FEB-2021 Lab tests included Ultrasounds  Patient has underlying condition: Chron's disease. She has been for a long time on prenatal vitamins because of that. After pregnancy, doctor recommended she takes baby aspirin. Positive pregnancy test: 30/10/2020. Pregnancy dates: 2013(Spontaneous Abortion),2014(live, full term birth), 5/-/2015(Spontaneous Abortion),7/8/2020(Spontaneous Abortion).
sicker; Initial information was received on 18-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media.  This case involves patient (unknown demographic) who get sicker (illness), while patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), past vaccination(s) concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.   On an unknown date, the patient get sicker (illness) (non-serious, unknown latency) after the administration of INFLUENZA VACCINE.  Laboratory data was not provided.  It was not reported if the patient received a corrective treatment.  At the time of reporting the outcome of event was unknown.  There will be no information available on the batch number for this case.
My face became swollen and red. I called the Pharmacy when I got home and he told me to take a antihimstine within an hour my face was back to normal
Patient complained of dizziness and nausea.  Cold washcloth applied to neck.  Cold water offered. Patient feeling better after 30 minutes, and left the facility.
12/23/2021 not feeling well, post nasal drip and tired and 12/25/2021 home COVID test, then called physician on 12/28/2021. Called and spoke with physician regarding system. Confirmed the test was good for positive results.
Patient began to experience numbness in hands, fingers and face, Facial numbness was  worse on Left side. Patient then began to experience Left eye drooping. Left eye droop began to resolve on the morning of 12/4/2021. Patient was offered appointment with a provider and refused. She just wanted it reported to VAERS
SHINGLE OUTBREAK ABOVE 8-29-07 - OVER LEFT EYE -RED, ITCHY, RAISED , SCABBY AFTER 2 DAYS AFTER RASH APPEARED, TENDER TO TOUCH.  WENT TO MD ON 8-31-07 PRESCRIBED - VALTREX 1MG TIDX7D. ACYCLOVIR 800 MG 5 TIMES A DAYSX 7 DAYS
pain, in arms, back, neck  and headaches, for days full body hives on day 5
I had a stiff neck with flickers of a headache for about 3 days. In addition I have a background noise in my ears that has persisted. It is not a ringing but sounds like a consistent dull sound? Like highway noise at a distance. I have not had anything like this in my life. I hope it goes away!
Pt had come back on 3/1/06 with red swollen R arm. Pt's father stated that it had developed a bump so he proceeded to remove band-aid and massage with his hand. Pt ended up developing cellulitis in that spot.
After 2-3 hrs. pt. returned to pharmacy with hives on both arms, swelling of eyes (watering), itchy throat and hands began to swell. Pt. given 2 - 25 mg BENADRYL and referred wife to immediately go to urgent care. The need for EPIPEN didn't seem necessary at time.
pt had brief (less than 1 minute) tonic sz follow c/o stomachache approx 24 hrs p/shots; vomiting x 2 in next few hrs but otherwise rapidly recoverd;
rt arm and shoulder pain with edema; rt arm and shoulder pain with edema/joint pain; rt arm and shoulder pain with edema; body aches; headache; tired; not feeling well; This is a spontaneous report from a contactable consumer. A 68-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 04Mar2021 17:15 (Batch/Lot Number: EN6204) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included pain, stage 3 kidney failure, a fib, auto immune, osteoporosis and many med sides effects from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included gabapentin (GABAPENTIN), atenolol (ATENOLOL), chlorthiazide (CHLORTHIAZIDE), vitamin b complex (VITAMIN B), calcium (CALCIUM) taken for an unspecified indication, start and stop date were not reported. On 04Mar2021 patient experienced rt arm and shoulder pain with edema, joint pain, body aches, headache, tired, not feeling well. The patient did not received treatment. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Within a few minutes of given flu shot employee Stated: dizziness, "I don't feel well", employee asked and was given bottle of water. Witnessed: sips of water taken then syncopal episode; sweating, facial flushness then pale, skin hot to touch. Code White initiated; employee moved to floor, blood pressure machine initiated; juice given when employee became alert and oriented; then snack given. Employee stated he had not eaten since breakfast which was a bowl of cereal.  Code White team offered Emergency Department treatment but employee declined. Once stable, employee ambulated out of EOH with coworker who came in with employee also for flu shot, but declined. Stated "I haven't eaten either."
Second shot 2 or 3 years after the first; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 3 years ago).   In August 2021, the patient received the 2nd dose of Shingrix. In August 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, received 2nd dose of Shingrix late than the recommended time interval, which led to lengthening of vaccination schedule. The reporter asked did need to take 3rd shot.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 1:23 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 1:23 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 33.62 for dose administered on 13-Feb-2021 at 13:23.  No concomitant medications were reported.  Batch number 031L20A underwent temperature excursion on 12-Feb-2021 with temperature 29 degrees Fahrenheit and 35 degrees Fahrenheit between 9AM-11AM and on 13-Feb-2021 with temperature 32 degrees Fahrenheit at 09:00 AM. 3 vials of same batch number were moved to fridge on 09-Feb-2021, moved to clinic on 12-Feb-2021 and beyond use date for these 3 vials were reported as 10-Mar-2021. 30 vials of same batch number were moved to fridge on 09-Feb-2021, moved to clinic on 13-Jan-2021 and beyond use date for these 30 vials were reported as 10-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
Fever and chills: 24 hours; body aches (muscle pain/joint pain): 24 hours; headache: still going day 6; swollen, warm, throbbing, painful arm (angioedema) starting at injection site - each day has gotten worse and traveled down entire arm: still going day 6
About March 23, 2021 (3 weeks after 2nd covid Vaccine) I started experiencing the feeling of walking on rocks on the ball of my right foot,  Dr. thought low B12 level might be cause.  Corrected the B12 level but continued to experience the discomfort.  Started PT in October, 2021 to get some help.  About two weeks before that the intensity was lessening.  It subsided by the beginning of November, 2021.  Received Pfizer Covid Booster on Nov. 9, 2021.  By first week of Dec. 2021(three weeks after the booster vaccine) the problem started all over again and is continuing at this date.
Woke up with severe sore throat and developed stuffy/runny nose later that day. Felt weirder (off base / not normal). No headache / fever or chest congestion or ill feelings (stomach).
2/15-2/19 nightly headaches increasing in intensity each night. 2/20-2/25  nightly headaches with stabbing pain in left eye 2/26.. 2/22- saw Dr. /had CT. 2/24-returned to Dr. and was sent to ER due to high BP.  Hospital admission that evening. 2/26 Steroid treatment stopped headaches and eye pain. 2/27 released from hospital after BP was <160.  Diagnosis-migraines possibly triggered by vaccine.  Pain/nausea elevated BP and decreased food intake which caused low blood sodium levels. IV treatments to increase sodium and lower BP. Dizziness from low sodium and high BP created fall risk, so bed had alarm.  Bed confinement necessitated daily injections to prevent blood clots.  Twice daily blood tests done to monitor sodium and potassium levels + kidney function.
Information has been received from a nurse practitioner concerning a 16 year old female with penicillin allergy who on 12-FEB-2007 was vaccinated with a dose of HPV (lot #653736/0014U). There was no concomitant medication. On 12-FEB-2007 the patient developed large hives on her arms, trunk and face. Medical attention was sought and the patient was treated with Benadryl 100 mg. There were no laboratory or diagnostic tests performed. On 13-FEB-2007, the patient recovered. Additional information has been requested.
Significant  and irregular menstrual bleeding  started  shortly after the vaccine . Today is Sunday , so all doctors are closed ,  we will  take the patient to gynecologist tomorrow(Monday 12/6/2021).
Patient stated, "I got really sick after the second shot. My legs were so huge and full of water. Now my kidneys are failing. The vaccine brought on so much water. Now, I have high blood sugar levels and I never had that before."
Irregular Heart rate and Atrial Fibrillation.  Diarrhea, watery to soft stool ever since. Continuing still.
I experienced a ball size lymph node under my left arm which was very painful to touch. I also developed chills and body aches.
Very sore arm that was injected; Extreme fatigue for 24 hours; Mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 23Aug2021 at 16:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of the vaccination. On 23Aug2021 at 18:00, the patient experienced very sore arm that was injected, extreme fatigue for 24 hours and mild headache. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore arm that was injected and mild headache were resolved on an unknown date in Aug2021, while the clinical outcome of extreme fatigue was resolved on 24Aug2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
it was like she had COVID; it was like she had COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID:. The reporter is the patient.  A 62-year-old female patient received BNT162b2 (BNT162B2), on 30May2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 05Aug2021 as dose 2, single (Batch/Lot number: unknown) at the age of 60 years for covid-19 immunisation. The patient's relevant medical history included: "breast cancer" (not ongoing), notes: over 2 years but she still goes through blood work; "chemotherapy" (unspecified if ongoing), notes: over 2 years but she still goes through blood work. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "it was like she had COVID". The patient underwent the following laboratory tests and procedures: Cytogenetic analysis: negative, notes: all genetics for cancer was negative, including breast cancer. Clinical course: After Dose 2 she got so sick it was like she had COVID. Does not have cancer gene in her DNA. Does not know how that happened. The oncologist said there was so much medication, she couldn't begin to tell what gave her that. Patient had family history of hypertension and no family history of breast cancer.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300110131 same reporter/patient, different drug/event;US-PFIZER INC-202300110727 same reporter/patient, different dose/event;US-PFIZER INC-202300110726 same reporter/patient, different dose/event;
Feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling bad). At the time of the report, FEELING ABNORMAL (Feeling bad) outcome was unknown.            No concomitant medications were provided. No treatments were provided. Action taken with mRNA-1273 in response to the event was not applicable.
Patient is experiencing extreme pain from injection site to below the hand - Claims to be like nerve pain and only relieved w/NORCO.
Patient received moderna vaccine on 3/17/21 and 4/14/21. Presented to ER on 2/1/22 and found to be COVID positive. Admitted for cellulitis and treated with antibiotics for cellulitis. He completed dexamethasone though. Discharged on 2/9/22
inc redness & itchyness in a 9" x 9" area; poss cellulitis or react to vax; react tx w/Keflix PO for 7 days; recovered/resolving as of 28JUN93; last prev dose given MAY84; 4AUG93 office visit-fully recovered;
Experienced bad taste in my mouth right away, lips felt weird, breathing very raspy, chills, itching on head, ears, arms, headache, swallowing issues, stuffy nose, sinus pressure, extreme fatigue, dry mouth (felt like cotton in my mouth), temperature dropped.   Took about five days to feel okay. Took Benadryl (took twice with six hours between doses, took antihistmine,  Levocetiriine, used pro air quite often,    20 mg of Prednisone  at 2:30 am on the 22 and finally felt relief.  Dr.. was informed after I got better.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 29-year-old male patient received BNT162b2 (BNT162B2), on 02Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 29 years, in left arm for Covid-19 immunisation; CoviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN], start date: 20Jul2022, stop date: 24Jul2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19  (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, Covid-19. Clinical course: it was reported that Covid-19 treatment (Paxlovid) started at 21Jul2022 and stopped at 25Jul2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I went to the Pharmacy to get the seasonal Flu vaccine required for nursing school. I paid for it and filled the forms required by the pharmacy prior vaccine administration. The pharmacist failed to follow the five rights of medication administration and administered me a third dose of COVID vaccine. Once she realized her mistake, she administered me the Flu vaccine on the other arm, which was the vaccine that I was requesting since the beginning. I was very concern because I had my two dosis of COVID vaccine with Moderna (1st Moderna dose 3/5/2021 ; 2nd Moderna dose 4/6/2021) and the pharmacist said that is ok to have the 3rd dose with a different type of vaccine. Starting at 8:45pm the same day, I started with severe headache, malaise, and shoulder pain.
No known adverse effects; a patient received an expired dose of VAQTA; This spontaneous report has been received from a registered nurse, concerning to a patient of unknown age and gender.  The patient's concurrent conditions, medical history, past drug history, allergies and concomitant medications were not reported.  On 31-MAY-2019, the patient received an expired dose of Hepatitis A Vaccine, inactivated (VAQTA), administered intramuscularly (dose number and anatomical location were not provided) (lot#: R013515, expiration date: 30-MAY-2019) for prophylaxis. It was not known any adverse effects.
Patient received vaccine that was expired. Vaccine was drawn from a vial that was opened on 4/8/21. Patient informed on 6/4/21. Patient has not experienced any symptoms.
Left upper extremity DVT and pulmonary embolism diagnosed 2/24/2021. Arm swelling started 02/23/2021.
A non-serious, spontaneous report of rash has been received from a registered nurse concerning a 40-year-old female, subsequent to receiving H1N1. The patient's medical history and concomitant medications was not reported. The patient received H1N1 on 06-Oct-2009. On the same day, the patient broke out in a rash that has lasted more than ten days and at the time of the report, she still had a rash on her face. The event was ongoing.
No menstrual cycle as of 07/28/2021. 5-7 days late and counting
Patient developed cellulitis at the injection site. She presented to the emergency department on 11/12/20 and again to an urgent care center on 11/14/20. She was discharged on antibiotics without being admitted.
Patient complained of severe aches all over body after getting vaccine. No fever or nausea. Patient was very ill all through Saturday night but felt fine on Sunday.
Rash develops at injection site on 1/28,  10 days after vaccine.  No signs of insect bite, e.g. mosquito,flea or tick. Rash has a slight itch and is somewhat warm to the touch.  On 1/29 edges of rash are migrating some and appear more red than the middle.